See more : Zhejiang Sunriver Culture Co.,Ltd. (600576.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Tsuruha Holdings Inc. (3391.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tsuruha Holdings Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- ALKOSIGN LIMITED (ALKOSIGN.BO) Income Statement Analysis – Financial Results
- Shenzhen Highpower Technology Co., Ltd. (001283.SZ) Income Statement Analysis – Financial Results
- Pioneer High Income Fund, Inc. (PHT) Income Statement Analysis – Financial Results
- Trilogy Metals Inc. (TMQ) Income Statement Analysis – Financial Results
- Jardine Matheson Holdings Limited (JARB.L) Income Statement Analysis – Financial Results
Tsuruha Holdings Inc. (3391.T)
About Tsuruha Holdings Inc.
Tsuruha Holdings Inc. operates drugstores in Japan. It sells pharmaceutical and cosmetic products. As of October 15, 2021, the company operated 2,448 stores in Japan and 22 stores in Thailand. The company was founded in 1929 and is headquartered in Sapporo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,027.46B | 970.08B | 915.70B | 919.30B | 841.04B | 782.45B | 673.24B | 577.09B | 527.51B | 440.43B | 388.47B | 343.02B | 320.97B | 299.58B | 279.76B | 251.86B | 227.79B | 173.62B | 157.48B |
| Cost of Revenue | 715.19B | 676.72B | 644.22B | 652.58B | 596.77B | 558.66B | 480.40B | 409.85B | 378.10B | 316.05B | 278.90B | 245.74B | 230.17B | 215.91B | 202.69B | 183.45B | 165.37B | 127.71B | 116.63B |
| Gross Profit | 312.28B | 293.36B | 271.48B | 266.72B | 244.26B | 223.78B | 192.84B | 167.24B | 149.41B | 124.37B | 109.56B | 97.28B | 90.80B | 83.67B | 77.08B | 68.41B | 62.42B | 45.90B | 40.85B |
| Gross Profit Ratio | 30.39% | 30.24% | 29.65% | 29.01% | 29.04% | 28.60% | 28.64% | 28.98% | 28.32% | 28.24% | 28.20% | 28.36% | 28.29% | 27.93% | 27.55% | 27.16% | 27.40% | 26.44% | 25.94% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.65B | 2.72B | 2.56B | 2.00B | 1.96B | 9.11B | 1.28B |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 263.07B | 247.79B | 230.91B | 218.04B | 199.35B | 181.66B | 152.54B | 129.79B | 117.92B | 97.68B | 85.69B | 75.22B | 3.65B | 2.72B | 2.56B | 2.00B | 1.96B | 9.11B | 1.28B |
| Other Expenses | 1.00M | 895.00M | -200.00M | -562.00M | 1.37B | 1.57B | 152.60B | 1.55B | 1.20B | 826.00M | 960.00M | 1.03B | 776.00M | 661.00M | 576.00M | 649.22M | 837.04M | 607.19M | 554.63M |
| Operating Expenses | 263.07B | 247.79B | 230.91B | 218.34B | 199.25B | 181.95B | 152.60B | 130.17B | 118.07B | 97.47B | 85.46B | 75.27B | 49.18B | 46.05B | 43.85B | 38.02B | 33.79B | 24.49B | 21.68B |
| Cost & Expenses | 978.26B | 924.50B | 875.13B | 870.92B | 796.02B | 740.62B | 633.00B | 540.02B | 496.16B | 413.52B | 364.36B | 321.02B | 279.36B | 261.96B | 246.54B | 221.47B | 199.16B | 152.20B | 138.31B |
| Interest Income | 118.00M | 124.00M | 130.00M | 140.00M | 131.00M | 142.00M | 137.00M | 130.00M | 146.00M | 131.00M | 167.00M | 171.00M | 125.00M | 104.00M | 107.00M | 138.98M | 119.29M | 73.17M | 48.32M |
| Interest Expense | 1.55B | 1.30B | 802.00M | 634.00M | 509.00M | 526.00M | 391.00M | 301.00M | 237.00M | 16.00M | 32.00M | 14.00M | 16.00M | 17.00M | 23.00M | 22.06M | 30.31M | 14.32M | 20.09M |
| Depreciation & Amortization | 18.00B | 16.56B | 14.66B | 13.29B | 11.50B | 11.51B | 8.93B | 7.58B | 6.80B | 5.55B | 4.20B | 3.31B | 3.33B | 3.35B | 3.51B | 3.28B | 3.20B | 1.69B | 1.77B |
| EBITDA | 61.15B | 62.13B | 55.23B | 61.67B | 56.52B | 53.34B | 49.17B | 44.65B | 38.12B | 32.45B | 28.30B | 26.21B | 22.86B | 17.74B | 15.86B | 14.48B | 14.61B | 10.56B | 10.09B |
| EBITDA Ratio | 5.95% | 6.54% | 6.05% | 6.69% | 6.93% | 7.06% | 7.56% | 8.05% | 7.52% | 7.62% | 7.60% | 7.76% | 14.28% | 13.93% | 13.38% | 13.68% | 14.39% | 13.65% | 13.68% |
| Operating Income | 49.21B | 45.57B | 40.57B | 48.38B | 45.01B | 41.83B | 40.24B | 37.07B | 31.34B | 26.91B | 24.10B | 22.00B | 41.61B | 37.62B | 33.23B | 30.39B | 28.63B | 21.42B | 19.17B |
| Operating Income Ratio | 4.79% | 4.70% | 4.43% | 5.26% | 5.35% | 5.35% | 5.98% | 6.42% | 5.94% | 6.11% | 6.20% | 6.41% | 12.97% | 12.56% | 11.88% | 12.07% | 12.57% | 12.34% | 12.17% |
| Total Other Income/Expenses | -7.61B | -2.12B | -2.92B | -2.35B | -1.17B | 95.00M | 417.00M | 596.00M | -197.00M | 2.45B | 994.00M | 884.00M | 440.00M | -23.24B | -20.91B | -19.22B | -17.25B | -12.56B | -10.86B |
| Income Before Tax | 41.60B | 43.46B | 37.65B | 46.03B | 43.85B | 41.92B | 40.65B | 37.67B | 31.15B | 29.35B | 25.10B | 22.89B | 19.51B | 14.37B | 12.32B | 11.17B | 11.37B | 8.86B | 8.30B |
| Income Before Tax Ratio | 4.05% | 4.48% | 4.11% | 5.01% | 5.21% | 5.36% | 6.04% | 6.53% | 5.90% | 6.66% | 6.46% | 6.67% | 6.08% | 4.80% | 4.40% | 4.43% | 4.99% | 5.10% | 5.27% |
| Income Tax Expense | 14.73B | 14.81B | 13.23B | 16.51B | 13.41B | 14.86B | 14.22B | 12.27B | 11.56B | 12.14B | 10.17B | 9.42B | 8.91B | 6.48B | 5.75B | 5.11B | 5.12B | 3.81B | 3.52B |
| Net Income | 24.11B | 25.26B | 21.39B | 26.28B | 27.90B | 24.82B | 24.80B | 24.43B | 19.32B | 17.21B | 14.56B | 13.46B | 10.59B | 7.88B | 6.56B | 6.05B | 6.26B | 5.05B | 4.79B |
| Net Income Ratio | 2.35% | 2.60% | 2.34% | 2.86% | 3.32% | 3.17% | 3.68% | 4.23% | 3.66% | 3.91% | 3.75% | 3.92% | 3.30% | 2.63% | 2.34% | 2.40% | 2.75% | 2.91% | 3.04% |
| EPS | 495.85 | 519.88 | 440.58 | 542.02 | 576.84 | 513.83 | 515.25 | 484.54 | 405.73 | 362.36 | 305.25 | 284.22 | 224.87 | 166.24 | 138.34 | 127.58 | 132.25 | 57.45 | 58.12 |
| EPS Diluted | 493.47 | 518.50 | 439.18 | 539.87 | 574.79 | 511.69 | 511.40 | 480.53 | 401.07 | 358.29 | 301.58 | 281.87 | 223.59 | 165.83 | 138.17 | 127.49 | 131.99 | 57.23 | 57.78 |
| Weighted Avg Shares Out | 48.61M | 48.58M | 48.55M | 48.49M | 48.37M | 48.31M | 48.13M | 47.95M | 47.63M | 47.50M | 47.71M | 47.36M | 47.12M | 47.41M | 47.41M | 47.39M | 47.30M | 43.93M | 41.19M |
| Weighted Avg Shares Out (Dil) | 48.85M | 48.71M | 48.70M | 48.68M | 48.54M | 48.51M | 48.49M | 48.35M | 48.18M | 48.03M | 48.29M | 47.76M | 47.38M | 47.53M | 47.46M | 47.42M | 47.40M | 43.93M | 41.19M |
No news found for: 3391.T
Source: https://incomestatements.info
Category: Stock Reports